Historically, research into surgical treatment of Graves disease has assessed subtotal rather than total thyroidectomy. Most clinicians now recommend total thyroidectomy, but little information is available regarding quality-of-life (QOL) outcomes for this procedure. Our aim was to assess QOL after total thyroidectomy. This is a retrospective, pilot study of patients with Graves disease who underwent total thyroidectomy from 1991 to 2007 at a high-volume tertiary referral center in Toronto, Canada. Questionnaires addressing disease-specific symptoms and global QOL concerns were sent to 54 patients. Analyses included parametric and nonparametric tests to assess the differences between perception of symptoms and global QOL before and after surgery. Forty patients responded (response rate: 74%) at a median of 4.8 years postoperatively. On a 10-point scale, overall wellness improved from 4.1 preoperatively to 8.7 postoperatively (p < 0.001). Patients recalled missing less work or school after surgery (7.8 vs. 1.1 days/year; p = 0.001). Overall satisfaction with the procedure was high. On average, symptoms improved within 32 days of surgery, and all symptoms showed substantial improvement. This is the first North American study to assess QOL outcomes of patients with Graves disease after total thyroidectomy. Patients experienced marked and rapid improvement in QOL postoperatively. These findings suggest that total thyroidectomy is a safe and effective treatment.
Introduction
Graves disease (GD) is a relatively common autoimmune thyroid disorder that affects approximately 0.5% of the population and is responsible for up to 80% of cases of hyperthyroidism. 1 Thyroid hormone excess leads to a variety of signs and symptoms that includes fatigue; weight loss despite increased appetite; heat intolerance; difficulty sleeping; tachycardia; dyspnea; resting tremor; palpitations; irritability; proptosis (protruding eyes); impaired vision; goiter; warm, moist, and smooth skin; menstrual irregularity; loose stools; erectile dysfunction; decreased libido; and muscle weakness, among others. 1-4 These symptoms contribute to an overall poor quality of life (QOL), an important feature of GD that notably does not correlate well with objective biochemical tests. 1,4-9 Consequently, several European studies have linked outcomes of various GD therapies to QOL using patient questionnaires. 6, 10, 11 Treatment options for GD include antithyroid medication (ATM), radioactive iodine (RAI) ablation of the thyroid, and thyroidectomy, although debate is considerable over which of these should be chosen as first-line therapy. 1, 5, [12] [13] [14] No evidence definitively supports one modality over another, 1, 5, 12 as most prospective, randomized, controlled trials comparing these 3 treatments have found them similarly effective. 6,10,15 As a result, GD treatment is typically based on patient and physician preference, and knowledge of QOL outcomes is therefore particularly important. 5, 12, 16 Currently, ATM is used as primary therapy in most GD patients in Europe and Asia, while RAI is generally considered the first-line therapy of choice in the United States. 1, 12, [16] [17] [18] No published data describe typical therapeutic practices in Canada. Beta-adrenergic blockers are added to these therapeutic regimens to provide rapid relief from symptoms such as tremor, palpitations, and sweating. Thyroidectomy is the least commonly employed treatment and tends to be reserved as primary therapy for pregnant or lactating patients not controlled on ATMs, patients with concurrent thyroid nodules suspicious for malignancy, patients with a large goiter and local compressive symptoms, and patients who fear RAI or prefer rapid and definitive treatment. 1, 12, 16 Another controversial issue in GD treatment has been the extent of thyroid resection during thyroidectomy. Due to a perception of increased rates of complications with total thyroidectomy and because of the inevitable hypothyroid state that ensues, subtotal thyroidectomy has historically been the routine form of surgery for treatment of GD. 2 Most clinicians now recommend total thyroidectomy for GD. 5, 12, 13, 19, 20 However, many of the randomized, controlled trials comparing outcomes of ATM with RAI and surgery employed subtotal rather than total thyroidectomy, potentially limiting the validity of their findings. 6, 10, 15, 21 Importantly, these studies form the basis of current decision making in GD treatment and are also the current source of information regarding the association of GD therapies to QOL. 6, 10, 11 We sought to examine the outcomes of patients with GD after total thyroidectomy with respect to GD-specific symptoms and global QOL, through the use of a detailed, retrospective questionnaire.
Patients and methods
Because of the retrospective nature of the data collection and the relatively small sample size, this study is considered a pilot study. Study approval was obtained from the Mount Sinai Hospital Research Ethics Board (MSH REB 08-0122-E).
In August 2008, a survey was mailed to all GD patients treated by total thyroidectomy at Mount Sinai Hospital, a high-volume tertiary referral center in Toronto, Canada. Fifty-four patients with GD referred by 13 endocrinologists were operated on by the study's senior authors (J.L.F and I.J.W.) between April 1991 and December 2007. These patients were identified using the hospital's Health Records Services database, and GD was the primary indication for surgery in each patient. Study participation was voluntary, and questionnaire completion was considered as implied consent. Respondents were asked to return the questionnaires by mail. In October 2008, a coinvestigator (L.H.K) contacted nonrespondents to complete the survey by telephone. Data acquisition ended by December 2008.
The survey was designed to elicit information related to GD patients' pre-and postoperative QOL. No validated GD-specific QOL questionnaires exist, so the research group developed the current questionnaire based on consensus, using known symptoms of GD and several items from the Medical Outcome Study 36-item Short Form Health Status Survey 22 and the QoL2004 survey, 6 which have previously been used to evaluate disease-specific and global QOL issues in GD patients. 6, 9 Since most of the items consist of a simple list of known symptoms, many forms of validation (e.g., convergent, predictive, divergent) are not applicable in the same sense as they are when a more theoretical "construct" is being measured, and the use of expert consensus generally provides a high degree of both face and content validity.
Using a 5-point Likert scale, respondents commented on the severity of GD symptoms before total thyroidectomy (from "very severe" to "not a problem"). They rated the postoperative change in symptom severity on a 5-point Likert scale (from "much worse" to "greatly improved"). Additional questions involved rating their pre-and postoperative overall wellness and their overall satisfaction with the procedure, their surgical scar, and the need for lifelong thyroid replacement therapy. They were also asked to estimate the number of days of work or school missed annually due to GD symptoms before and after surgery and to estimate how soon after surgery their symptoms improved. The survey also included objective measures such as the rate of discontinuation of beta-blocker medications. Finally, they were asked whether they would recommend total thyroidectomy to friends or family affected with GD.
Data were entered into an Excel file and imported into IBM Statistical Package for the Social Sciences software (v. 20.0 for Windows) for statistical analysis. Data were initially assessed descriptively (means, standard deviations, and ranges for continuous and ordinal data, and frequencies and percentages for categorical data). Although most of the data are ordinal in nature and the use of inferential statistics is not optimal in this situation, this was considered preferable to a large number of simple frequency tables and chi-square tests, and this also facilitated the comparison of severity of various symptoms. Moreover, the sample size was believed to be sufficiently substantial to allow the use of inferential statistics in this instance. 23 Questionnaires returned by mail and telephone were assessed for comparability using chi-square tests and independent samples t tests, then combined for subsequent analysis. Those with a lengthier follow-up were also compared with those with a shorter follow-up (initially split at the median of 4.8 years, and also at 8 years to further investigate a longer follow-up time) to assess comparability, and combined for subsequent analyses. Questionnaire data were then analyzed using independent samples t tests for 2-group comparisons (e.g., by sex) and paired samples t testing where appropriate (wellness and days of work/school missed).
Associations between age and responses were assessed
